These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6222067)

  • 1. Modification of chemically induced diabetes in rats by vitamin E. Supplementation minimizes and depletion enhances development of diabetes.
    Slonim AE; Surber ML; Page DL; Sharp RA; Burr IM
    J Clin Invest; 1983 May; 71(5):1282-8. PubMed ID: 6222067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of diethyldithiocarbamate on diabetogenic action of alloxan in rats.
    Kurahashi M; Masui H; Yoshimoto S; Wakabayashi I; Sakamoto K
    Diabetes Res Clin Pract; 1993 Jan; 19(1):39-47. PubMed ID: 8386078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of different vitamin E levels on lipid peroxidation in streptozotocin-diabetic rats.
    Vannucchi H; Araujo WF; Bernardes MM; Jordão Júnior AA
    Int J Vitam Nutr Res; 1999 Jul; 69(4):250-4. PubMed ID: 10450529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
    Yale JF; Grose M; Videtic GM; Marliss EB
    Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against the diabetogenic effect of feeding tert-butylhydroquinone to rats prior to the administration of streptozotocin.
    Nishizono S; Hayami T; Ikeda I; Imaizumi K
    Biosci Biotechnol Biochem; 2000 Jun; 64(6):1153-8. PubMed ID: 10923784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldehyde and xanthine oxidase activities in tissues of streptozotocin-induced diabetic rats: effects of vitamin E and selenium supplementation.
    Ghaffari T; Nouri M; Saei AA; Rashidi MR
    Biol Trace Elem Res; 2012 Jun; 147(1-3):217-25. PubMed ID: 22231435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral utilization of a glucose load after alloxan and streptozotocin in the rat and chicken: a comparison.
    Stellenwerf WA; Hazelwood RL
    Gen Comp Endocrinol; 1979 Oct; 39(2):131-40. PubMed ID: 159201
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective effect of vitamin E against alloxan-induced mouse hyperglycemia.
    Takemoto K; Doi W; Masuoka N
    Biochim Biophys Acta; 2016 Apr; 1862(4):647-650. PubMed ID: 26723540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets: decrease of islet manganosuperoxide dismutase.
    Asayama K; Kooy NW; Burr IM
    J Lab Clin Med; 1986 May; 107(5):459-64. PubMed ID: 3517203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on streptozotocin diabetes.
    Ganda OP; Rossini AA; Like AA
    Diabetes; 1976 Jul; 25(7):595-603. PubMed ID: 132382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K1 alleviates streptozotocin-induced type 1 diabetes by mitigating free radical stress, as well as inhibiting NF-κB activation and iNOS expression in rat pancreas.
    Varsha MK; Thiagarajan R; Manikandan R; Dhanasekaran G
    Nutrition; 2015 Jan; 31(1):214-22. PubMed ID: 25466668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemiluminescence as an index of drug-induced free radical production in pancreatic islets.
    Asayama K; English D; Slonim AE; Burr IM
    Diabetes; 1984 Feb; 33(2):160-3. PubMed ID: 6229439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against streptozotocin-induced diabetes by superoxide dismutase.
    Robbins MJ; Sharp RA; Slonim AE; Burr IM
    Diabetologia; 1980 Jan; 18(1):55-8. PubMed ID: 6444904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of alloxan and streptozotocin induced diabetes in rats: differential effects on microsomal drug metabolism.
    Vega P; Gaule C; Mancilla J; Del Villar E
    Gen Pharmacol; 1993 Mar; 24(2):489-95. PubMed ID: 8482528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction.
    Lacković Z; Salković M
    Life Sci; 1990; 46(1):49-54. PubMed ID: 1688991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucoprivic feeding is impaired by lateral or fourth ventricular alloxan injection.
    Ritter S; Murnane JM; Ladenheim EE
    Am J Physiol; 1982 Sep; 243(3):R312-7. PubMed ID: 6214195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vitamin E on alloxan-induced mouse diabetes.
    Kamimura W; Doi W; Takemoto K; Ishihara K; Wang DH; Sugiyama H; Oda S; Masuoka N
    Clin Biochem; 2013 Jun; 46(9):795-8. PubMed ID: 23473942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
    Okamoto H; Yamamoto H
    Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
    Liu Z; Li J; Zeng Z; Liu M; Wang M
    Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of early metabolic events resulting from the administration of the two diabetogenic agents alloxan and streptozotocin.
    Veleminsky J; Burr IM; Stauffacher W
    Eur J Clin Invest; 1970 Aug; 1(2):104-8. PubMed ID: 5450973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.